← Editorial teamCoverage area
Standards editor
This GLP articles covering The provider scoring rubric, Corrections and how they are logged, Affiliate disclosure rules, Medical-claim language limits, Source requirements for a published figure, When a provider is excluded from a ranking.
Published by This GLP Editorial Team. This collection brings together sourced articles on the ranking rules, the corrections log, and what this site will not publish. These pages explain available evidence; they do not provide a clinical opinion or claim firsthand treatment experience.
Coverage
- The provider scoring rubric
- Corrections and how they are logged
- Affiliate disclosure rules
- Medical-claim language limits
- Source requirements for a published figure
- When a provider is excluded from a ranking
Articles in this collection
68 pieces- Can You Smoke Weed on Ozempic? What Cannabis-User Cohorts FoundSafety
- Can You Take Ozempic With Levothyroxine? The Tablet Form Is the One StudiedSafety
- Can You Take Phentermine With Ozempic? No Trial Has Tested It, One Tried LiraglutideSafety
- Can You Take Ozempic While Breastfeeding? 8 Mothers, No Drug Detected in MilkSafety
- Can a Pill Keep Weight Off After the Injection? ATTAIN-MAINTAIN, Read CarefullyEvidence
- Tirzepatide Against Real Clinical Practice: What SURPASS-EARLY FoundEvidence
- Do GLP-1 Drugs Help Alzheimer's? The Trials and the Records DisagreeEvidence
- Semaglutide Starting Dose: 0.25 mg, and What Compounding ChangesFormats
- VK2735 Phase 2 VENTURE Trial: 14.7% Weight Loss in 13 WeeksEvidence
- GLP-1 Use and Bowel Function After Lumbar Fusion: 117 PatientsSafety
- GLP-1 Drugs and ERCP Complications: A TriNetX Cohort of 21,818Evidence
- Is Semaglutide Safe for People With HIV? Four Studies So FarSafety
- Parkinson's Incidence and Motor Symptoms on GLP-1 Drugs: An 82-Study ReviewEvidence
- Can a GLP-1 Cause Ketoacidosis? 470 Reports, Most of Them HospitalizedSafety
- FLOW Trial Cardiovascular Subgroups: Semaglutide's Numbers Needed to TreatEvidence
- Tirzepatide Sleep Apnea Results by Age, BMI and SeverityEvidence
- Semaglutide Dose Escalation and Insulin Reduction in Type 2 DiabetesEvidence
- GLP-1 Drugs at the Start of Hemodialysis: Hospitalization and DeathEvidence
- Atrial Fibrillation Risk: GLP-1 vs SGLT-2 vs DPP-4 InhibitorsEvidence
- Can a GLP-1 Cause Thiamine Deficiency? Six Cases Say It CanSafety
- Do GLP-1 Drugs Raise the Risk of Aspiration Pneumonia?Safety
- Do GLP-1 Drugs Cause Acid Reflux? Three Databases Say More ReportsSafety
- GLP-1 Drugs and Overdose Risk: Five Comparators in VA DataEvidence
- Do GLP-1 Drugs Help Carpal Tunnel Syndrome? Fewer Diagnoses, Same SurgeriesEvidence
- How Many People Use Compounded GLP-1 Drugs? Records Catch 8.2%Evidence
- Do GLP-1 Drugs Prevent Contrast Kidney Injury? 8.7% Against 25.7%Evidence
- Who Qualifies for Semaglutide for Liver Disease? Fibrosis Stage F2 to F3Formats
- Do GLP-1 Drugs Cause Arrhythmia? Three Intervals, Two Cross OneSafety
- Do GLP-1 Drugs Help Antipsychotic Weight Gain? 9.8% Off, Half BackEvidence
- Depression Risk on GLP-1 Drugs vs DPP-4 and SGLT2 InhibitorsEvidence
- Do GLP-1 Drugs Cause Kidney Stones? Nobody Has Run That ComparisonEvidence
- Is Tirzepatide Better Than Dulaglutide? One Trial Is 92% of the AnswerEvidence
- GLP-1 Discounts vs Seller Disclosure: Dose Ladders and State ListsFormats
- Adolescent Suicidality on GLP-1 Drugs vs Lifestyle Intervention and MetforminEvidence
- Advertised vs Billed GLP-1 Prices: Every Correction, by TypeFormats
- Do GLP-1 Drugs Help Ulcerative Colitis? Remission Was 66.7% Against 25.3%Evidence
- What BMI Do You Need for a GLP-1? The Cut-Off Is a ConventionEvidence
- What Should a GLP-1 Provider Actually Do? Five PillarsFormats
- Does Taking a GLP-1 Before Pregnancy Raise Preeclampsia Risk? The Studies SplitEvidence
- GLP-1 Drugs in Children and Adolescents: 18 Randomized Trials PooledEvidence
- Do You Lose Muscle on a GLP-1? And What Comes Back Is FatEvidence
- GLP-1 Drugs and Mortality in Type 2 Diabetes With a BMI Under 27Evidence
- Mortality on GLP-1 Drugs in Hidradenitis Suppurativa: A Record StudyEvidence
- Why Do GLP-1 Drugs Cause Nausea? And Why It Does Not Predict Weight LossSafety
- Insulin Resistance in PCOS on GLP-1 Drugs: A Four-Trial Meta-AnalysisEvidence
- GLP-1 Price Spread Across Sellers: The Range and the Middle HalfFormats
- Which GLP-1 Has the Worst Side Effects? It Depends on the OutcomeEvidence
- GLP-1 Drugs and Rotator Cuff Repair Complications in Type 2 DiabetesEvidence
- Do GLP-1 Drugs Affect Spinal Fusion Surgery? It Depends on the OperationEvidence
- Atrial Fibrillation After Ablation on GLP-1 Drugs: An Umbrella ReviewEvidence
- GLP-1 Prescribing After a Heart Attack or Stroke: Czech Registry DataEvidence
- Do You Need Vitamins on a GLP-1? Over 60% Eat Below the Iron RequirementSafety
- GLP-1 Dose Ladders: How Many Price Rungs Sellers PublishFormats
- Promotional GLP-1 Pricing: First-Month Rates, Codes and Struck PricesFormats
- Is a GLP-1 Better Than Metformin? Nobody Has Run That TrialEvidence
- GLP-1 Price Changes Between Two Readings of the Same SellersFormats
- Does Semaglutide Reduce Alcohol Use? One Trial Found a 13.7-Point GapEvidence
- Oral Semaglutide in Early Alzheimer's Disease: The evoke and evoke+ TrialsEvidence
- Semaglutide in MASH: ESSENCE Phase 3 Results at 72 WeeksEvidence
- Do GLP-1 Drugs Help Migraine? Triptan Use Fell 7%, Which Is Not a TreatmentEvidence
- Semaglutide and Cognitive Signs in Psychiatric Patients: 13,007 RecordsEvidence
- Can You Trust GLP-1 Advice on TikTok? Likes Do Not Track QualityEvidence
- Do GLP-1 Drugs Affect Fertility? 25 Men, and No Trial Measured PregnancyEvidence
- Switching to Tirzepatide and Liver Fibrosis Scores: 182 PatientsEvidence
- Tirzepatide 2.5 mg vs 5 mg in Japanese Adults Without DiabetesEvidence
- Stopping Semaglutide in Type 1 Diabetes: Time in Range After WithdrawalEvidence
- GLP-1 Seller State Coverage: Who Publishes Where They ShipFormats
- GLP-1 Sellers Billing Every Four Weeks: Thirteen Charges a YearFormats